Funding Agency

Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Research Demonstration--Cooperative Agreements (U18)
Project #
1U18FD004012-01
Application #
8130313
Study Section
Special Emphasis Panel (ZFD1-SRC (99))
Project Start
2010-09-17
Project End
2012-09-16
Budget Start
2010-09-17
Budget End
2011-09-16
Support Year
1
Fiscal Year
2010
Total Cost
Indirect Cost

  Institution

Name
Aeras Global Tb Vaccine Foundation
Department
Type
DUNS #
039593699
City
Rockville
State
MD
Country
United States
Zip Code
20850

  Publications

Brennan, Michael J; Tanner, Rachel; Morris, Sheldon et al. (2017) The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010-2014. Clin Vaccine Immunol 24:
Chen, Tingting; Blanc, Caroline; Eder, Anke Z et al. (2016) Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction. J Infect Dis 214:300-10
Hoft, Daniel F; Blazevic, Azra; Selimovic, Asmir et al. (2016) Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial. EBioMedicine 7:278-86
Achkar, Jacqueline M; Chan, John; Casadevall, Arturo (2015) B cells and antibodies in the defense against Mycobacterium tuberculosis infection. Immunol Rev 264:167-81
Achkar, Jacqueline M; Chan, John; Casadevall, Arturo (2014) Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis. Cold Spring Harb Perspect Med 5:a018432
Achkar, Jacqueline M; Casadevall, Arturo (2013) Antibody-mediated immunity against tuberculosis: implications for vaccine development. Cell Host Microbe 13:250-62
Yu, Xian; Prados-Rosales, Rafael; Jenny-Avital, Elisabeth R et al. (2012) Comparative evaluation of profiles of antibodies to mycobacterial capsular polysaccharides in tuberculosis patients and controls stratified by HIV status. Clin Vaccine Immunol 19:198-208